OncoCyte Corp (OCX)
NASDAQ:OCX
Holding OCX?
Track your performance easily

OncoCyte (OCX) Financial Statements

410 Followers

OncoCyte Financial Overview

OncoCyte's market cap is currently ―. The company's EPS TTM is $-4.256; its P/E ratio is -0.71; OncoCyte is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 104.00K$ 429.00K$ 463.00K$ 297.00K$ -3.55M
Gross Profit$ 50.00K$ 248.00K$ 272.00K$ 10.00K$ 2.00M
EBIT$ -4.52M$ -5.12M$ -8.33M$ 5.96M$ 9.32M
EBITDA$ -4.20M$ -4.69M$ -7.88M$ 6.43M$ 8.49M
Net Income Common Stockholders$ -4.59M$ -6.69M$ -8.64M$ 1.63M$ -45.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.30M$ 14.24M$ 17.87M$ 12.40M-
Total Assets$ 74.72M$ 81.59M$ 87.51M$ 82.80M-
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -9.30M$ -14.24M$ -17.87M$ -12.40M$ 0.00
Total Liabilities$ 52.02M$ 39.10M$ 43.94M$ 39.34M-
Stockholders Equity$ 22.74M$ 37.56M$ 43.58M$ 37.93M-
Cash Flow-
Free Cash Flow$ -6.17M$ -2.04M$ -8.49M$ 8.67M$ -10.45M
Operating Cash Flow$ -5.98M$ -2.26M$ -8.61M$ 8.67M$ -9.65M
Investing Cash Flow$ -191.00K$ -1.30M$ 1.92M$ -18.31M$ -802.00K
Financing Cash Flow$ 9.85M$ -30.00K$ 12.27M$ -28.00K$ -100.00K
Currency in USD

OncoCyte Earnings and Revenue History

OncoCyte Debt to Assets

OncoCyte Cash Flow

OncoCyte Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis